Earnings and Growth Analysis : Kazia Therapeutics (NASDAQ:KZIA)

Earnings results for Kazia Therapeutics (NASDAQ:KZIA)

Kazia Therapeutics Limited is estimated to report earnings on 12/31/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.

Analyst Opinion on Kazia Therapeutics (NASDAQ:KZIA)

There is no enough data Analyst Ratings

There is not enough analysis data for Kazia Therapeutics.

Dividend Strength: Kazia Therapeutics (NASDAQ:KZIA)

Kazia Therapeutics does not currently pay a dividend. Kazia Therapeutics does not have a long track record of dividend growth.

Insiders buying/selling: Kazia Therapeutics (NASDAQ:KZIA)

In the past three months, Kazia Therapeutics insiders have not sold or bought any company stock. Only 1.00% of the stock of Kazia Therapeutics is held by insiders. Only 9.19% of the stock of Kazia Therapeutics is held by institutions.

Earnings and Valuation of Kazia Therapeutics (NASDAQ:KZIA

Earnings for Kazia Therapeutics are expected to grow in the coming year, from ($0.69) to ($0.64) per share. The P/E ratio of Kazia Therapeutics is -6.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Kazia Therapeutics is -6.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Kazia Therapeutics has a P/B Ratio of 8.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here